Drug class
Attention Deficit Hyperactivity Disorder (ADHD) Agents comprise a therapeutic drug class utilized to manage the core symptoms of ADHD, including inattention, impulsivity, and hyperactivity. Read more about Attention Deficit Hyperactivity Disorder (ADHD) Agents
261 drugs in this class 104 manufacturers
Attention Deficit Hyperactivity Disorder (ADHD) Agents comprise a therapeutic drug class utilized to manage the core symptoms of ADHD, including inattention, impulsivity, and hyperactivity.
This class encompasses both central nervous system stimulants, such as amphetamines and methylphenidate derivatives, and non-stimulant medications, including selective norepinephrine reuptake inhibitors and central alpha-2 adrenergic agonists.
Mechanistically, these agents enhance prefrontal cortical functioning and neurotransmission by increasing extracellular levels or signaling of norepinephrine and dopamine.
Beyond their primary indication for ADHD in pediatric and adult populations, select agents within this class carry approved indications for conditions such as narcolepsy and binge eating disorder.
Attention Deficit Hyperactivity Disorder (ADHD) Agents comprise a therapeutic drug class utilized to manage the core symptoms of ADHD, including inattention, impulsivity, and hyperactivity
Attention Deficit Hyperactivity Disorder (ADHD) Agents comprise a therapeutic drug class utilized to manage the core symptoms of ADHD, including inattention, impulsivity, and hyperactivity This class encompasses both central nervous system stimulants, such as amphetamines and methylphenidate derivatives, and non-stimulant medications, including selective norepinephrine reuptake inhibitors and central alpha-2 adrenergic agonists Mechanistically, these agents enhance prefrontal cortical functionin...
This class encompasses both central nervous system stimulants, such as amphetamines and methylphenidate derivatives, and non-stimulant medications, including selective norepinephrine reuptake inhibitors and central alpha-2 adrenergic agonists Mechanistically, these agents enhance prefrontal cortical functioning and neurotransmission by increasing extracellular levels or signaling of norepinephrine and dopamine Beyond their primary indication for ADHD in pediatric and adult populations, select ag...
Following a drug class requires a free Physicians Office Resource account.
